SpringWorks Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 5.45 million. Net loss was USD 325.1 million compared to USD 277.42 million a year ago.

Basic loss per share from continuing operations was USD 5.15 compared to USD 5.21 a year ago.